Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Zhao XS"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 53
Tytuł:
Postoperative fibrinogen-to-albumin ratio acting as an indicator of futile recanalization in patients with successful thrombectomy.
Autorzy:
Tang T; Department of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Li D; Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian, China.
Fan TP; Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian, China.
Guo LJ; Department of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Lan XY; Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian, China.
Bi CJ; Department of Anesthesiology, Central Hospital of Dalian University of Technology, Dalian, China.
Boltze J; School of Life Sciences, University of Warwick, Coventry, UK.
Thomas AM; The Russell H. Morgan Department of Radiology and Radiological Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Zhao XS; Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian, China.
Mo M; Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian, China.
Zhao MH; Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian, China.
Ji XM; Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
Li S; Department of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2023 Dec; Vol. 13 (12), pp. e3301. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Stroke*/diagnosis
Brain Ischemia*/etiology
Endovascular Procedures*/adverse effects
Humans ; Treatment Outcome ; Retrospective Studies ; Thrombectomy/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and evaluation of short-form version of the Constitution in Chinese Medicine Questionnaire: study a new and best brief instrument of Chinese medicine for health management.
Autorzy:
Bai MH; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Li ZQ; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Wang HY; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Ma XL; College of Nursing, Hebei University, Baoding, 071000, China.
Wang ZL; College of Nursing, Jiujiang University, Jiujiang, 332000, China.
Li SJ; Pharmacy Department, The NO.5 Hospital of Baoding, Baoding, 071000, China.
Dong SY; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhang ZL; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Li WL; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Chen SQ; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Cai YY; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhao XS; School of Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Wang J; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. .
Wang Q; National Institute of TCM, Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. .
Pokaż więcej
Źródło:
Chinese medicine [Chin Med] 2023 Oct 30; Vol. 18 (1), pp. 140. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: Phase I-II clinical trial.
Autorzy:
Zhao XS; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Shi LJ; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ning BL; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhao ZM; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Li XX; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhu MH; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhang YB; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Fu J; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2023 May; Vol. 11 (5), pp. e857.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Irritable Bowel Syndrome*/therapy
Probiotics*/therapeutic use
Humans ; Quality of Life ; Diet ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
Autorzy:
Liu XX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China.
Pan XA; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Gao MG; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Kong J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen Z; Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2023 Apr; Vol. 45 (2), pp. 195-203. Date of Electronic Publication: 2022 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
MDS1 and EVI1 Complex Locus Protein*/genetics
MDS1 and EVI1 Complex Locus Protein*/therapeutic use
Humans ; Gene Rearrangement ; Prognosis ; Retrospective Studies ; Risk Assessment ; Virus Integration ; Hematopoietic Stem Cell Transplantation/methods ; Gene Expression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic value of post-transplantation Wilms' tumor gene 1 expression in acute myeloid leukaemia subgroup according to different pre-transplant disease status.
Autorzy:
Wang K; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Liu XX; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.; Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China.
Qin YZ; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Chang YJ; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Sun YQ; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Yan CH; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Wang Y; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Zhang XH; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.
Huang XJ; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.; Beijing Hightrust Diagnostics, Co., Ltd, Beijing, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Zhao XS; Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Dec; Vol. 44 (6), pp. e265-e268. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Letter
MeSH Terms:
Wilms Tumor*/genetics
Wilms Tumor*/pathology
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Kidney Neoplasms*/genetics
Kidney Neoplasms*/pathology
Humans ; Prognosis ; Genes, Wilms Tumor
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype.
Autorzy:
Xu N; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Lai YY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen WM; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Oct; Vol. 44 (5), pp. 892-899. Date of Electronic Publication: 2022 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Monosomy*
Abnormal Karyotype ; Adult ; Humans ; Karyotype ; Mutation ; Neoplasm Recurrence, Local ; Prognosis ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjects.
Autorzy:
Ma N; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Guo JP; Department of Immunology, School of Basic Medical Sciences, Peking University. NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
Zhao XY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Xu LP; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Zhang XH; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Wang Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Mo XD; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Zhang YY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Liu YR; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Zhao XS; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Cheng YF; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Liu KY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Huang XJ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Chang YJ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Pokaż więcej
Źródło:
HLA [HLA] 2022 Oct; Vol. 100 (4), pp. 312-324. Date of Electronic Publication: 2022 Jun 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Graft Rejection*
HLA Antigens*
Alleles ; Allografts ; Antibodies ; Humans ; Isoantibodies ; Prevalence ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Origin of Excellent Charge Storage Properties of Defective Tin Disulphide in Magnesium/Lithium-Ion Hybrid Batteries.
Autorzy:
Fan X; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.; School of Material Science and Technology, North University of China, Taiyuan, 030051, Shanxi, People's Republic of China.
Tebyetekerwa M; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.; Dow Centre for Sustainable Engineering Innovation, School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
Wu Y; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
Gaddam RR; Department of Chemical Engineering, Indian Institute of Science Education and Research, Bhopal, India.
Zhao XS; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia. george.zhao@uq.edu.au.
Pokaż więcej
Źródło:
Nano-micro letters [Nanomicro Lett] 2022 Aug 24; Vol. 14 (1), pp. 177. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Glycoside constituents with various antioxidant effects from fresh Cynomorium songaricum .
Autorzy:
Ma FP; Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China.; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Yu L; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Yang Y; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Li DX; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Shen CY; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Zhao XS; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Luo Q; Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China.; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.; Guangdong Provincal Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China.
Pokaż więcej
Źródło:
Journal of Asian natural products research [J Asian Nat Prod Res] 2022 Aug; Vol. 24 (8), pp. 784-793. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiac Glycosides*
Cynomorium*/chemistry
Antioxidants/pharmacology ; Glycosides/pharmacology ; Molecular Structure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging.
Autorzy:
Chen YZ; Department of Cardiology, Beijing Jishuitan Hosptial, No. 31 East Street, Xinjiekou, XiCheng, Beijing, 100035, China. .
Zhao XS; Department of Cardiology, Beijing Jishuitan Hosptial, No. 31 East Street, Xinjiekou, XiCheng, Beijing, 100035, China.
Yuan JS; Department of Cardiology, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, XiCheng, Beijing, 100037, China.
Zhang Y; Department of Magnetic Resonance Imaging, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, XiCheng, Beijing, 100037, China.
Liu W; Department of Cardiology, Beijing Jishuitan Hosptial, No. 31 East Street, Xinjiekou, XiCheng, Beijing, 100035, China. .
Qiao SB; Department of Cardiology, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, XiCheng, Beijing, 100037, China. .
Pokaż więcej
Źródło:
Biology of sex differences [Biol Sex Differ] 2022 Jul 07; Vol. 13 (1), pp. 37. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Hypertrophic*/complications
Cardiomyopathy, Hypertrophic*/diagnostic imaging
Cardiomyopathy, Hypertrophic*/pathology
Ventricular Remodeling*
Adult ; Contrast Media/pharmacology ; Ethanol/therapeutic use ; Female ; Gadolinium/pharmacology ; Heart Septum/diagnostic imaging ; Heart Septum/pathology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Sex Characteristics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT.
Autorzy:
Fan ZY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Han TT; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zuo W; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Lv M; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Sun YQ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhang YY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhao XY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.; Collaborative Innovation Center of Hematology, Beijing 100044, China.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2022 Jun 23; Vol. 208 (3), pp. 332-339.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytomegalovirus Infections*
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*/adverse effects
Immune Reconstitution*
CD8-Positive T-Lymphocytes ; Humans ; Prognosis ; Retrospective Studies ; Transplantation, Homologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation.
Autorzy:
Pan X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Gao M; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Sun Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhou Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang K; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu L; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Jun; Vol. 44 (3), pp. 510-517. Date of Electronic Publication: 2022 Jan 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/pathology
Leukemia, Myelomonocytic, Chronic*/diagnosis
Leukemia, Myelomonocytic, Chronic*/genetics
Leukemia, Myelomonocytic, Chronic*/therapy
Leukemia, Myelomonocytic, Juvenile*
Flow Cytometry ; Humans ; Neoplasm, Residual/diagnosis ; Prognosis ; Recurrence ; Transplantation, Homologous ; WT1 Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
Autorzy:
Kong J; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Gao MG; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Qin YZ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Wang Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Yan CH; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.
Sun YQ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Chang YJ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Xu LP; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.
Zhang XH; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Liu KY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Huang XJ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, 100044, China.
Zhao XS; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China. zhao..; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China. zhao..; Collaborative Innovation Center of Hematology, Peking University, Beijing, China. zhao..
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jan 03; Vol. 22 (1), pp. 11. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Histone-Lysine N-Methyltransferase/*genetics
Leukemia, Myeloid, Acute/*genetics
Myelodysplastic Syndromes/*genetics
Myeloid-Lymphoid Leukemia Protein/*genetics
Neoplasm Recurrence, Local/*genetics
Oncogene Proteins, Fusion/*genetics
Disease-Free Survival ; Female ; Follow-Up Studies ; Gene Rearrangement/genetics ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/surgery ; Male ; Middle Aged ; Myelodysplastic Syndromes/mortality ; Myelodysplastic Syndromes/surgery ; Neoplasm Recurrence, Local/mortality ; Neoplasm, Residual ; Postoperative Period ; Predictive Value of Tests ; Prognosis ; Progression-Free Survival ; Recurrence ; Retrospective Studies ; Transplantation, Homologous ; Tumor Burden/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.
Autorzy:
Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Kong J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jia JS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Lu SY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Gong LZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Ruan GR; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 2949-2956. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Interferon-alpha*/therapeutic use
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/drug therapy
Consolidation Chemotherapy ; Disease-Free Survival ; Humans ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
Autorzy:
Han TT; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang YN; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Sun YQ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Kong J; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang FR; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang ZD; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Cheng YF; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Yan CH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; National Clinical Research Center for Hematologic Disease, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Jun; Vol. 23 (3), pp. e13544. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Herpesvirus 6, Human*
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Roseolovirus Infections ; Virus Activation ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Autorzy:
Deng DX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wen JJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
Cheng YF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Yan CH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen YH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Han W; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang FR; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang JZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. zhao..; Collaborative Innovation Center of Hematology, Peking University, Beijing, China. zhao..
Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Mar 19; Vol. 21 (1), pp. 292. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Biomarkers, Tumor/*metabolism
Leukemia, Myeloid, Acute/*therapy
Neoplasm Recurrence, Local/*epidemiology
WT1 Proteins/*metabolism
Adolescent ; Biomarkers, Tumor/analysis ; Bone Marrow/pathology ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Incidence ; Infant ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/pathology ; Male ; Neoplasm Recurrence, Local/pathology ; Neoplasm, Residual ; Prognosis ; Risk Assessment/methods ; Transplantation, Homologous ; WT1 Proteins/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
2020 Roadmap on Zinc Metal Batteries.
Autorzy:
Xu C; School of Physics and Electronics, Hunan University, Changsha, 410082, Hunan, P. R. China.
Zhang Y; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, 92 Xidazhi Street, Harbin, 150001, P. R. China.
Zhang N; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, 92 Xidazhi Street, Harbin, 150001, P. R. China.
Liu X; Institute for Sustainable Energy & Department of Chemistry, Shanghai University, 99 Shangda Road, Shanghai, 200444, P. R. China.
Yi J; Institute for Sustainable Energy & Department of Chemistry, Shanghai University, 99 Shangda Road, Shanghai, 200444, P. R. China.
Liu X; MOE of the Key Laboratory of Bioinorganic and Synthetic Chemistry; School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, P. R. China.
Lu X; MOE of the Key Laboratory of Bioinorganic and Synthetic Chemistry; School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, P. R. China.
Ru Q; Guangdong Engineering Technology Research Center of Efficient Green Energy and Environmental Protection Materials, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics and Telecommunication Engineering, South China Normal University, Guangzhou, 510006, P. R. China.
Lu H; State Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou, 510641, P. R. China.; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
Peng X; State Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou, 510641, P. R. China.
Zhao XS; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
Ma J; School of Physics and Electronics, Hunan University, Changsha, 410082, Hunan, P. R. China.; Key Laboratory of Materials Processing and Mold (Zhengzhou University), Ministry of Education, Zhengzhou University, Zhengzhou, 450002, Henan, P. R. China.
Pokaż więcej
Źródło:
Chemistry, an Asian journal [Chem Asian J] 2020 Nov 16; Vol. 15 (22), pp. 3696-3708. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Affinity of Skp to OmpC revealed by single-molecule detection.
Autorzy:
Pan S; Beijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, and Department of Chemical Biology, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, 100871, China.
Yang C; Beijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, and Department of Chemical Biology, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, 100871, China.
Zhao XS; Beijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, and Department of Chemical Biology, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China. .; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, 100871, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Sep 10; Vol. 10 (1), pp. 14871. Date of Electronic Publication: 2020 Sep 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA-Binding Proteins/*metabolism
Escherichia coli/*metabolism
Escherichia coli Proteins/*metabolism
Molecular Chaperones/*metabolism
Periplasm/*metabolism
Porins/*metabolism
DNA-Binding Proteins/chemistry ; Escherichia coli/growth & development ; Escherichia coli Proteins/chemistry ; Molecular Chaperones/chemistry ; Porins/chemistry ; Protein Binding ; Protein Folding ; Single Molecule Imaging/methods ; Spectrometry, Fluorescence/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stabilising Cobalt Sulphide Nanocapsules with Nitrogen-Doped Carbon for High-Performance Sodium-Ion Storage.
Autorzy:
Wu Y; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
Gaddam RR; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
Zhang C; School of Chemistry, Physics and Mechanical Engineering, Science and Engineering Faculty, Queensland University of Technology, Brisbane, QLD, 4001, Australia.
Lu H; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
Wang C; Institute of Materials for Energy and Environment, College of Materials Science and Engineering, Qingdao University, 308 Ningxia Road, Qingdao, 266071, People's Republic of China.
Golberg D; School of Chemistry, Physics and Mechanical Engineering, Science and Engineering Faculty, Queensland University of Technology, Brisbane, QLD, 4001, Australia.
Zhao XS; School of Chemical Engineering, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia. george.zhao@uq.edu.au.; Institute of Materials for Energy and Environment, College of Materials Science and Engineering, Qingdao University, 308 Ningxia Road, Qingdao, 266071, People's Republic of China. george.zhao@uq.edu.au.
Pokaż więcej
Źródło:
Nano-micro letters [Nanomicro Lett] 2020 Feb 12; Vol. 12 (1), pp. 48. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anaplastic Thyroid Carcinoma Histologically Mimicking a Plasmacytoma.
Autorzy:
Mo JH; Department of Pathology and Laboratory Medicine, UC Irvine School of Medicine, Irvine, CA 92617, USA.
Tan D; Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA 92697, USA.
Zhao XS; Department of Pathology and Laboratory Medicine, UC Irvine School of Medicine, Irvine, CA 92617, USA.
Tjoa T; Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA 92697, USA.
Wang BY; Department of Pathology and Laboratory Medicine, UC Irvine School of Medicine, Irvine, CA 92617, USA.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2020 Jan 08; Vol. 10 (1). Date of Electronic Publication: 2020 Jan 08.
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 53

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies